// App-Quantinova.ai

1382 : Host Genomic Variants and Risk of Infections During Induction Treatment in Childhood Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Agata Wesolowska

Principal Investigators

  • Birgitte Lausen

  • Louise Borst

  • Kirsten Korup Rasmussen

  • Klaus Muller

  • Helge Klungland

  • Ramneek Gupta

  • Kjeld Schmiegelow

Medical Centers

  • Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark

  • The Institute of Gynaecology, Obstetrics and Paediatrics, The Faculty of Health Sciences, The University of Copenhagen, Copenhagen, Denmark

  • Department of Hematology, Rigshospitalet, Copenhagen, Denmark

  • Pediatric Clinic, Juliane Marie Center, Copenhagen, Denmark,

  • Clinic for Paediatric and Adolescent Medicine, The University Hospital Rigshospitalet, Copenhagen, Copenhagen, Denmark

  • Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway

  • Dept. of Pediatrics, St Olavs Hospital, Trondheim, Norway

Locations

  • Denmark

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute lymphoblastic leukemia

  • Venous thrombosis

Biomarkers

  • Galectin-3

  • Transcription factor Maf

Drug/Treatment

  • Methotrexate

  • Asparaginase

  • Vincristine

  • Doxorubicin

  • Prednisone

Outcome

  • N/A

Study Design

  • adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved